Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Pretreatment Cancer-Related Cognitive Impairment in Hodgkin Lymphoma Patients

V. Juríčková, D. Fayette, J. Jonáš, I. Fajnerová, T. Kozák, J. Horáček

. 2023 ; 30 (10) : 9028-9038. [pub] 20231005

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc24001086

BACKGROUND: Cancer-related cognitive impairment (CRCI) is one of the most serious side effects of cancer that negatively impacts the quality of life of cancer patients and survivors. There is evidence of CRCI in Hodgkin lymphoma patients (HL); however, there is a lack of studies examining the presence of cognitive deficits before starting any treatment in HL patients. METHODS: Forty adult patients (N = 40) newly diagnosed with HL (with no previous cancer diagnoses) and 40 healthy controls (N = 40) matched for age, sex, education, and premorbid intellect completed the neuropsychological battery and subjective and objective measures of affective distress and quality of life. RESULTS: The results showed impairment in three out of six cognitive domains: verbal memory and learning, speed of processing/psychomotor speed, and abstraction/executive functions in the HL patients before the initiation of any treatment. The speed of processing/psychomotor speed domain is negatively correlated with depression. CONCLUSION: Cognitive deterioration in verbal memory and learning and abstraction/executive functions domains in HL patients seems to occur before the initiation of treatment independently of anxiety, depression, or physical symptoms. This suggests that HL itself may cause cognitive deficits in these cognitive domains. However, the underlying causes of CRCI still remain unclear.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24001086
003      
CZ-PrNML
005      
20240807135610.0
007      
ta
008      
240109s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/curroncol30100652 $2 doi
035    __
$a (PubMed)37887552
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Juríčková, Veronika $u Center for Advanced Studies of Brain and Consciousness, National Institute of Mental Health, 25067 Klecany, Czech Republic $u First Faculty of Medicine, Charles University, 12108 Prague, Czech Republic $1 https://orcid.org/0000000166189799
245    10
$a Pretreatment Cancer-Related Cognitive Impairment in Hodgkin Lymphoma Patients / $c V. Juríčková, D. Fayette, J. Jonáš, I. Fajnerová, T. Kozák, J. Horáček
520    9_
$a BACKGROUND: Cancer-related cognitive impairment (CRCI) is one of the most serious side effects of cancer that negatively impacts the quality of life of cancer patients and survivors. There is evidence of CRCI in Hodgkin lymphoma patients (HL); however, there is a lack of studies examining the presence of cognitive deficits before starting any treatment in HL patients. METHODS: Forty adult patients (N = 40) newly diagnosed with HL (with no previous cancer diagnoses) and 40 healthy controls (N = 40) matched for age, sex, education, and premorbid intellect completed the neuropsychological battery and subjective and objective measures of affective distress and quality of life. RESULTS: The results showed impairment in three out of six cognitive domains: verbal memory and learning, speed of processing/psychomotor speed, and abstraction/executive functions in the HL patients before the initiation of any treatment. The speed of processing/psychomotor speed domain is negatively correlated with depression. CONCLUSION: Cognitive deterioration in verbal memory and learning and abstraction/executive functions domains in HL patients seems to occur before the initiation of treatment independently of anxiety, depression, or physical symptoms. This suggests that HL itself may cause cognitive deficits in these cognitive domains. However, the underlying causes of CRCI still remain unclear.
650    _2
$a dospělí $7 D000328
650    _2
$a lidé $7 D006801
650    12
$a Hodgkinova nemoc $x komplikace $7 D006689
650    _2
$a kvalita života $7 D011788
650    12
$a kognitivní dysfunkce $x etiologie $x diagnóza $x psychologie $7 D060825
650    _2
$a exekutivní funkce $7 D056344
650    _2
$a kognice $7 D003071
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Fayette, Dan, $u Center for Advanced Studies of Brain and Consciousness, National Institute of Mental Health, 25067 Klecany, Czech Republic $u Third Faculty of Medicine, Charles University, 10000 Prague, Czech Republic $d 1981- $7 xx0321144
700    1_
$a Jonáš, Juraj $u Center for Advanced Studies of Brain and Consciousness, National Institute of Mental Health, 25067 Klecany, Czech Republic $u Faculty of Humanities, Charles University, 18200 Prague, Czech Republic
700    1_
$a Fajnerová, Iveta $u Center for Advanced Studies of Brain and Consciousness, National Institute of Mental Health, 25067 Klecany, Czech Republic $1 https://orcid.org/0000000273993029 $7 xx0225831
700    1_
$a Kozák, Tomáš $u Third Faculty of Medicine, Charles University, 10000 Prague, Czech Republic $u Department of Clinical Hematology, University Hospital Královské Vinohrady, Šrobárova 50, 10034 Prague, Czech Republic
700    1_
$a Horáček, Jiří $u Center for Advanced Studies of Brain and Consciousness, National Institute of Mental Health, 25067 Klecany, Czech Republic $u Third Faculty of Medicine, Charles University, 10000 Prague, Czech Republic
773    0_
$w MED00165427 $t Current oncology $x 1718-7729 $g Roč. 30, č. 10 (2023), s. 9028-9038
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37887552 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240807135605 $b ABA008
999    __
$a ok $b bmc $g 2049598 $s 1210780
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 30 $c 10 $d 9028-9038 $e 20231005 $i 1718-7729 $m Current oncology $n Curr. oncol. $x MED00165427
LZP    __
$a Pubmed-20240109

Najít záznam

Citační ukazatele

Možnosti archivace